2024-03-01 18:26:00
The National Agency for the Safety of Medicines and Health Products (ANSM) reported the February 26, 2024 that the Avaxim 80 U pediatric vaccine (Laboratory: Sanofi Pasteur) was made available normally since February 26, 2024.
Avaxim 80 U pediatric vaccine is indicated for active immunization once morest infection caused by the hepatitis A virus in children aged 12 months to 15 years inclusive. This vaccine should be administered in accordance with official recommendations.
In order to secure the situation in France as much as possible and to preserve available stocks, the sale and export of the medicine by wholesale distributors abroad is prohibited from the publication of this information sheet on the website of the National Agency for the Safety of Medicines and Health Products (ANSM), in application of public health law 2016-41 published in the Official Journal on January 27, 2016 and the provisions of articles L.5121-30 and L.5124 -17-3 of the Public Health Code. This measure prohibiting sales outside the national territory, or to wholesale distributors for export, must be applied and respected until the medicine is made available normally, allowing a continuous and appropriate supply to the national market.
Source: National Agency for Medicines and Health Products (ANSM).
1709318419
#Avaxim #pediatric #vaccine #available..
